[Federal Register Volume 73, Number 148 (Thursday, July 31, 2008)]
[Notices]
[Pages 44758-44759]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Drug Testing Advisory Board (DTAB) will meet on August 19 and 20, 2008.
    The meeting is open and will include discussion of DTAB's 
``Exploring the Science and Experience of Testing for Prescription 
Drugs in the Non-Regulated Workplace.''
    Attendance by the public will be limited to space available. To 
make arrangements to attend or to request special accommodations for 
persons with disabilities, please communicate with DTAB's Program 
Assistant, Ms. Giselle Hersh (see contact information below).
    SAMHSA would like to ensure that advisory committee meetings 
proceed in an orderly fashion, are conducted in a

[[Page 44759]]

safe and secure environment, that the right of free speech is 
protected, and that the ability of SAMHSA Advisory Committees to 
accomplish their objectives is not disrupted. Therefore, the following 
procedures will be followed by DTAB:
     Attendees may be subject to security screening, such as 
presenting identification, passing through metal detectors, and 
inspection of briefcases, packages, etc.
     Any interested person who wishes to be assured of the 
right to make an oral presentation during the Open Public Hearing 
portion of the DTAB meeting must register with Ms. Hersh before the 
meeting. Those who have not registered before the meeting will only be 
invited to speak at the discretion of the Chair and should submit their 
request to the Designated Federal Official on the day of the meeting.
     Open Public Hearing participants who are designated to 
speak may be questioned only by the Chair or other DTAB members.
     Audience members may not present comments or questions to 
the Committee unless recognized by the Chair.
     Attendees at the meeting are asked to maintain order and 
not display behavior that is disruptive to the meeting (i.e., shouting 
from the audience, loud outbursts).
     We ask that attendees not approach the DTAB table area 
during the meeting without permission from the Chair or the Designated 
Federal Official.
     The DTAB Chair or Designated Federal Official will note on 
the record any disruptive behavior and will ask the person to cease the 
behavior or else leave the meeting room.
    Substantive program information, a summary of the meeting, and a 
roster of committee members may be obtained as soon as possible after 
the meeting, either by accessing the SAMHSA Committee Web site, https://www.nac.samhsa.gov/DTAB/index.aspx, or by contacting Ms. Hersh. The 
transcript of the meeting will also be available on the SAMHSA 
Committee's Web site within three weeks after the meeting.
    Committee Name: Substance Abuse and Mental Health Services 
Administration, Drug Testing Advisory Board.
    Date/Time/Type: August 19-20, 2008, from 8:30 a.m. to 5 p.m.: Open.
    Place: 1 Choke Cherry Road, Sugarloaf Conference Room, Rockville, 
Maryland 20857.
    Contact: Ms. Giselle Hersh, Program Assistant, SAMHSA Drug Testing 
Advisory Board, 1 Choke Cherry Road, Room 2-1042, Rockville, Maryland 
20857, Telephone: 240-276-2605, Fax: 240-276-2610, E-mail: 
[email protected].

Toian Vaughn,
Committee Management Officer, Substance Abuse and Mental Health 
Services Administration.
[FR Doc. E8-17564 Filed 7-30-08; 8:45 am]
BILLING CODE 4162-20-P